TrialAntimicrobial agents and chemotherapy2017

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers.

Soo Youn Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.